Prognostic value of anxiety and depression in patients with chronic heart failure

Circulation

Volumn 110, Issue 22, 2004, Pages 3452-3456

  Jiang, Wei ^a   Kuchibhatla, Maragatha ^a   Cuffe, Michael S ^a   Christopher, Eric J ^a   Alexander, Jude D ^b   Clary, Greg L ^a   Blazing, Michael A ^a   Gaulden, Laura H ^a   Califf, Robert M ^a   Krishnan, Ranga R ^a   O'Connor, Christopher M ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b Shady Grove Adventist Hospital   (United States)

Author keywords

Anxiety; Depression; Heart failure; Prognosis

Indexed keywords

ANXIETY DISORDER; ARTICLE; CONTROLLED STUDY; DATA ANALYSIS; DEPRESSION; FEMALE; HEART FAILURE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREDICTION; PRIORITY JOURNAL; PROGNOSIS;

AGED; ANXIETY; CAUSE OF DEATH; DEPRESSION; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE, CONGESTIVE; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PSYCHOLOGICAL TESTS; SEVERITY OF ILLNESS INDEX; STROKE VOLUME;

EID: 20844438002     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000148138.25157.F9     Document Type: Article

References (56)

1. Jiang W, Krishnan RRK, O'Connor CM. Depression and heart disease: evidence of a link and its therapeutic implications. CNS Drugs. 2002;16:111-127.
2. Kubzansky LD, Kawachi I, Weiss S, Sparrow D. Anxiety and coronary heart disease: a synthesis of epidemiological, psychological, and experimental evidence. Ann Behav Med. 1998;20:47-58.
3. Conwell Y. Suicide in elderly patients. In: Schneider LS, Reynolds CT, Lebowitz BD, eds. Diagnosis and Treatment of Depression in Late Life. Washington, DC: American Psychiatric Press, Inc; 1996:397-418.
4. Haines AP, Imeson JD, Meade TW. Phobic anxiety and ischaemic heart disease. BMJ Clin Res Ed. 1987;295:297-299.
5. Kawachi I, Colditz GA, Ascgerui A, Rimm EB. Prospective study of phobic anxiety and risk of coronary artery heart disease in men. Circulation. 1994;89:1995-1997.
6. Allgulander C, Lavori PW. Excess mortality among 3,302 patients with "pure" anxiety neurosis. Arch Gen Psychiatry. 1991;48:599-602.
7. Wheeler EO, White PD, Reed EW, Cohen ME. Neurocirculatory asthenia (anxiety neurosis, effort syndrome, neurasthenia): a twenty-year follow-up study of one hundred and seventy-three patients. JAMA. 1950; 142:878-889.
8. Martin RL, Cloninger CR, Guze SB, Clayton PJ. Mortality in a follow-up of 500 psychiatric outpatients. Arch Gen Psychiatry. 1985;42:47-54.
9. Moser DK, Dracup K. Is anxiety early after myocardial infarction associated with subsequent ischemic and arrhythmic events? Psychosom Med. 1996;58:395-401.
10. Frasure-Smith N, Lesperance F, Talajic M. The impact of negative emotions on prognosis following myocardial infarction: is it more than depression? Health Psychol. 1995;14:388-398.
11. Lane D, Carroll D, Ring C, Beevers DG, Lip GY. Mortality and quality of life 12 months after myocardial infarction: effects of depression and anxiety. Psychosom Med. 2001;63:221-230.
12. Zipfel A, Schneider A, Wild B, Lowe B, Junger J, Haass M, Sack FU, Bergmann G, Herzog W. Effect of depression symptoms on survival after heart transplantation. Psychosom Med. 2002;64:740-747.
13. Denollet J, Brutsaert DL. Personality, disease severity, and the risk of long-term cardiac events in patients with decreased ejection fraction after myocardial infarction. Circulation. 1998;97:167-173.
14. Frasure-Smith N, Lesperance F. Depression and other psychological risks following myocardial infarction. Arch Gen Psychiatry. 2003;60:627-636.
15. Jiang W, Alexander J, Christopher E, Kuchibhatla M, Gaulden LH, Cuffe MS, Blazing MA, Davenport C, Califf RM, Krishnan RR, O'Connor CM. Effect of depression on mortality and morbidity in patients with congestive heart failure. Arch Intern Med. 2001;161:1849-1856.
16. Spielberger CD, Gorsuch RL, Lushene R, Vagg PR, Jacobs GA. Manual for the State-Trait Anxiety Inventory. Palo Alto, Calif: Consulting Psychologists Press; 1983.
17. Beck A, Ward C, Mendelson M. An inventory for measuring depression. Arch Gen Psychiatry. 1961;4:561-571.
18. Massie BM, Shah NB. Evolving trends in the epidemiologic factors of heart failure: rationale for preventive strategies and comprehensive disease management. Am Heart J. 1997;133:703-712.
19. Ho KK, Anderson KM, Kannel WB, Grossman W, Levy D. Survival after the onset of congestive heart failure in Framingham Heart Study subjects. Circulation. 1993;88:107-115.
20. Bart BA, Shaw LK, McCants CB Jr, Fortin DF, Lee KL, Califf RM, O'Connor CM. Clinical determinants of mortality in patients with angiographically diagnosed ischemic or nonischemic cardiomyopathy. J Am Coll Cordiol. 1997;30:1002-1008.
21. Konstam V, Salem D, Puler H, Konstam V, Salem D, Pouleur H, Kostis J, Gorkin L, Shumaker S, Mottard I, Woods P, Konstam MA, Yusuf S, for the SOLVD Investigators. Baseline quality of life as a predictor of mortality and hospitalizations in 5,025 patients with congestive heart failure. Am J Cardiol 1996;78:890-895.
22. Kawachi I, Sparrow D, Vokonas PS, Weiss ST. Symptoms of anxiety and risk of coronary heart disease. Circulation. 1994;90:2225-2229.
23. Barlow DH. Anxiety and Its Disorders. New York, NY: Guilford Press: 1988.
24. Eaker ED, Pinsky J, Castelli WP. Myocardial infarction and coronary death among women: psychosocial predictors from a 20-year follow-up of women in the Framingham Study. Am J Epidemiol. 1992;135: 854-864.
25. Clark LA. The anxiety and depression disorders: descriptive psychopathology and differential diagnosis. In: Kendl OC, Watson D, eds. Anxiety and Depression: Distinctive and Overlapping Features. New York, NY: Academic Press; 1989:83-129.
26. Breier A, Charney DS, Heninger GR. Major depression in patients with agoraphobia and panic disorder. Arch Gen Psychiatry. 1984;41:1129-1135.
27. Parmelee P, Katz I, Lawton MP. Anxiety and its association with depression among institutionalized elderly. Am J Geriatr Psychiatry. 1993;1:65-79.
28. Beekman AT, de Beurs E, van Balkom AJ, Degg DJ, van Dyck R, van Tilburg W. Anxiety and depression in later life: concurrence and communality of risk factors. Am J Psychiatry. 2000;157:89-95.
29. Tellegen A, Structures of mood and personality and their relevance to assessing anxiety, with an emphasis on self-report. In: Tuma AH, Maser JD, eds. Anxiety and the Anxiety Disorders. Hillsdale. NJ: Erlbaum; 1985.
30. Frasure-Smith N, Lesperance F, Gravel G, Masson A, Juneau M, Bourassa MG. Long-term survival differences among low-anxious, high-anxious and repressive copers enrolled in the Montreal Heart Attack Readjustment Trial. Psychosom Med. 2002;64:571-579.
31. Herrmann C, Brand-Driehorst S, Buss U, Ruger U. Effects of anxiety and depression on 5-year mortality in 5,057 patients referred for exercise testing. J Psychosom Res. 2000;48:455-462.
32. Clark LA, Watson D. Tripartite model of anxiety and depression: psychometric considerations and taxonomic implications. J Abnorm Psychol. 1991;100:316-336.
33. Starkman MN, Camerson OG, Ness RM, Zelnik T. Peripheral catecholamine levels and symptoms of anxiety: studies in patients with and without pheochromocytoma. Psychosom Med. 1990;52:129-142.
34. Sevy S, Papadimtriou GN, Surmont DW, Goldman S, Mendlewicz J. Noradrenergic function in generalized anxiety disorder, major depressive disorder, and healthy subjects. Biol Psychiatry. 1989;25:141-152.
35. Taggart P, Gibbons D, Somerville W. Some effects of motor-car driving on the normal and abnormal heart. BMJ. 1969;4:130-134.
36. Taggart P, Carruthers M, Somerville W. Electrocardiogram, plasma catecholamines, and lipids, and their modification by oxyprenolol when speaking before an audience. Lancet. 1973;2:341-346.
37. Benson H, Alexander S, Feldman CL. Decreased premature ventricular contractions through use of the relaxation response in patients with stable ischemic heart disease. Lancet. 1975;1:380-382.
38. Weiss T, Engel BT. Operant conditioning of heart rate in patients with premature ventricular contractions. Psychosom Med. 1971;33:301-321.
39. Tullen JHM, Bruijn JA, de Man KJ, van der Velden, Papplinkhuizen L, Manin't Veld AJ. Anxiety and autonomic regulation in major depressive disorder: an exploratory study. J Affect Disord. 1996;40:61-71.
40. Yeragani VK, Pohl R, Berger R, Balon R, Srinivasan K. Decreased heart rate variability in panic disorder patients: a study of power-spectral analysis of heart rate. Psychiatry Res. 1993;46:89-103.
41. Thayer JF, Friedman BH, Borkovec TD. Autonomic characteristics of generalized anxiety disorder and worry. Biol Psychiatry. 1996;39:255-266.
42. Watkins LL, Grossman P. Association of depressive symptoms with reduced baroreflex cardiac control in coronary artery disease. Am Heart J. 1999;137:453-457.
43. Carney RM, Saunders RD, Freedland KE, Stein P, Rich MW, Jaffee AS. Association of depression with reduced heart rate variability in coronary artery disease. Am J Cardiol. 1995;76:562-564.
44. Pitzalis MV, Iacoviello M, Todarello O, Fioretti A, Guida P, Massari F, Mastropasqua F, Russo GD, Rizzon P. Depression but not anxiety influences the autonomic control of heart rate after myocardial infarction. Am Heart J. 2001;141:765-771.
45. Hughes JW, Stoney CM. Depressed mood is related to high-frequency heart rate variability during stressors. Psychosom Med. 2000;62:796-803.
46. Krittayaphong R, Cascio WE, Light KC, Sheffield D, Golden RN, Finkel JB, Glekas G, Koch GG, Sheps DS. Heart rate variability in patients with coronary artery disease: differences in patients with higher and lower depression scores. Psychosom Med. 1997;59:231-235.
47. Schneier FR, Blanco C, Campeas R, Lewis-Fernandez R, Lin SH, Marshall R, Schmidt AB, Sanchez-Lacay JA, Simpson HB, Liebowitz MR. Citalopram treatment of social anxiety disorder with comorbid major depression. Depress Anxiety. 2003;17:191-196.
48. Rickels K, Zaninelli R, McCafferty J, Bellew K, Iyengar M, Sheehan D. Paroxetine treatment of generalized anxiety disorder: a double-blind, placebo-controlled study. Am J Psychiatry. 2003;160:749-756.
49. Classman AH, O'Connor CM, Califf RM, Swedberg R, Schwarts P, Bigger JT Jr, Krishnan KR, van Zyl LT, Swenson JR, Finkel MS, Landau C, Shapiro PA, Pepine CJ, Mardekian J, Harrison WM, Barton D, McIvor M. for the Sertraline Antidepressant Heart Attack Randomization Trial (SADHEART) Group. Sertraline treatment of major depression in patients with acute MI or unstable angina. JAMA. 2002;288:701-709.
50. Writing Committee for the ENRICHD Investigators. Effects of treating depression and low perceived social support on clinical events after myocardial infarction. JAMA. 2003;289:3106-3116.
51. Serebruany VL, Glassman AH, Malinin AI, Nemeroff CB, Musselman DL, van Zyl LT, Finkel MS, Krishnan KR, Gaffney M, Harrison W, Califf RM, O'Connor CM, for the Sertraline Antidepressant Heart Attack Randomization Trial Study Group. Platelet/endothelial biomarkers in depressed patients treated with the selective serotonin reuptake inhibitor sertraline after acute coronary events. Circulation. 2003;108:939-944.
52. Nelson JC, Kennedy JS, Pollock BG, Laghrissi-Thode F, Narayn M, Nobler MS, Robin DW, Gergel I, McCafferty J, Roose S. Treatment of major depression with amitriptyline and paroxetine in patients with ischemic heart disease. Am J Psychiatry. 1999;156:1024-1028.
53. Roose SP, Glassman AH, Giardina EG, Johnson LL, Walsh BT, Bigger JT Jr. Cardiovascular effects of imipramine and bupropion in depressed patients with congestive heart failure. J Clin Psychopharmacol. 1987;7:247-251.
54. Byrne A, Byrne DG, The effect of exercise on depression, anxiety and other mood states: a review. J Psychosom Res. 1993;37:565-574.
55. Lang AJ. Brief intervention for co-occurring anxiety and depression in primary care: a pilot study. Int J Psychiatry Med. 2003;33:141-154.
56. Lidbeck J. Group therapy for somatization disorders in primary care: maintenance of treatment goals of short cognitive-behavioural treatment one-and-a-half-year follow-up. Acta Psychiatr Scand. 2002;107:449-456.